中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 12
Dec.  2011
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2011  >  27(12): 1259-1261

HBV mother-to-child transmission block-agreement and controversy

Research funding:

 

  • Received Date: 2011-07-22
  • Published Date: 2011-12-20
    Abstract
  • Hepatitis B virus (HBV) infection is one of the most severe public issue due to its serious harmful clinical outcomes such as cirrhosis or HCC.The mother-to-child transmission (MTCT, vertical transmission) is the main cause leading to chronic HBV infections.Though joint HBV immune prophylaxis with hepatitis B vaccine and hepatitis B immunoglobulin (HBIG) are given within 24hrs after birth for all neonates whose mothers are HBV positive, about 10% of them suffer from HBV infection in their early life, even in pregnant women with a high HBV DNA serum load.This paper discusses the thesis concerning on agreement and controversy regarding the MTCT.

     

    • FullText(HTML)
    • References(9)
  • [1]European Association for the Study of the Liver.EASL Clini-cal Practice Guidelines:Management of chronic hepatitis B[J].J Hepatol, 2009, 50:227-242.
    [2]Petrova M, Kamburov V.Breastfeeding and chronic HBV in-fection:Clinical and social implications[J].World J Gastro-enterol, 2010, 16 (40) :5042-5046.
    [3] Shi Z, Li X, Ma L, et al. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis[J]. Int J Infect Dis, 2010, 14 (7) : e622-634.
    [4]Shao ZJ, Zhang L, Xu JQ, et al.Mother-to-infant trans-mission of hepatitis B virus:a Chinese experience[J].JMed Virol, 2011, 83 (5) :791-795.
    [5]Shi Z, Yang Y, Ma L, et al.Lamivudine in late pregnancy tointerrupt in utero transmission of hepatitis B virus:a system-atic review and meta-analysis[J].Obstet Gynecol, 2010, 116 (1) :147-159.
    [6]Xu WM, Cui YT, Wang L, et al.Lamivudine in late pregnan-cy to prevent perinatal transmission of hepatitis B virus infec-tion:a multicentre, randomized, double-blind, placebo-controlled study[J].J Viral Hepat, 2009, 16 (2) :94-103.
    [7]van Zonneveld M, van Nunen AB, Niesters HG, et al.Lami-vudine treatment during pregnancy to prevent perinatal trans-mission of hepatitis B virus infection[J].J Viral Hepat, 2003, 10 (4) :294-297.
    [8]Wiseman S, D'Souza S, Kostkova P, et al.A Year on-Na-tional Resource for Infection Control[J].J Hosp Infect, 2006, 63 (Suppl 1) :S6y1.
    [9]Elefsiniotis IS, Tsoumakas K, Papadakis M, et al.Importance ofmaternal and cord blood viremia in pregnant women with chron-ic hepatitis B virus infection[J].Eur J Intern Med, 2011, 22 (2) :182-186.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3409) PDF downloads(873) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[3590]YesterdayPV[6562]TodayIP[554]TodayPV[728]Online[41]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return